THE FORMATION OF PRECIPITATES IN THE BLOOD IN VITRO BY ACID SALVARSAN SOLUTIONS by Joseph, Don R.
THE  FORMATION  OF  PRECIPITATES  IN  THE  BLOOD 
IN VITRO BY ACID SALVARSAN SOLUTIONS.* 
By  DON  R. JOSEPH. 
(From  the  Department  of  Physiology  and  Pharmacology  of  the  Rockefeller 
Institute  for Medical  Research,  New  York.) 
H.  E.  Hering  1  called  attention  to  the  difference in  toxicity be- 
tween the acid and the alkaline solutions of salvarsan.  Since that 
time,  numerous  writers  have  commented  upon  the  comparative 
toxicity of these two solutions, but as far as I have seen, only two-- 
Willige  2 and AuerS--have mentioned the concentration of the acid 
solution in connection with its toxicity.  Auer showed recently that 
the toxicity of this solution varies inversely with the dilution. 
In connection with the experiments described in a  former paper, * 
a large number of mixtures, in vitro, of blood and acid solutions of 
salvarsan  of  different  concentrations  were  examined  for  precipi- 
tates.  In the course of these experiments, the following facts were 
noted  which  may  be  of  importance  and  which  may  possibly  be 
connected with Auer's observations on the relation between toxicity 
and the concentration of the acid solution. 
Very  weak  solutions  of  acid  salvarsan  (o.I  per  cent.)  produce 
with blood in vitro  no precipitate,  or at least no precipitate that is 
easily seen.  The blood retains its normal consistency.  This is true 
even if the volume of the  salvarsan solution be  from one to three 
times that  of the blood to which it is added.  The amount of pre- 
cipitate produced in  the blood  increases with  the concentration of 
the acid salvarsan  solution employed, so that  after the addition of 
a  I  per cent., or stronger, solution of salvarsan, the precipitate may 
be so heavy that the blood practically loses its fluidity and the test 
tube  can  sometimes even be  inverted without  spilling  its  contents. 
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The loss of fluidity is due to the  formation  of a  precipitate and not 
to clotting. 
While,  as  stated  before,  a  comparatively  large  volume of  a  o.I 
per cent.  solution of acid salvarsan  may be added to blood without 
a  precipitate being formed,  a  very small amount of a  more concen- 
trated  solution  of  salvarsan  (o. 5  to  I  per  cent.  or  over)  gives  a 
definite  precipitate.  For  example,  in  one  experiment,  equal  parts 
of  a  o.I  per  cent.  solution  of  acid  salvarsan  and  blood  gave  no 
precipitate,  while  I  part of a  o. 5 per cent.  acid solution to 54 parts 
of blood gave a  definite precipitate.  The precipitate  is  formed ap- 
parently before the salvarsan can be diluted by the large volume of 
blood to which it is added. 
In brief,  then,  there  is a  fairly definite  relation  between the con- 
centration of the acid salvarsan  solution used, and the quantity and 
consistency  of  the  precipitate  which  it  forms  when  added  to  the 
blood in vitro. 
In the paper  5 mentioned above, it was shown that  a  precipitate is 
formed  in  the  blood stream  by acid  salvarsan  solutions,  just  as in 
vitro;  also,  that  the  precipitate  nearly  always disappears  from  the 
blood  stream  during  its  passage  through  the  lungs.  Now  if  the 
more concentrated  solutions of acid salvarsan  produce heavier pre- 
cipitates  than  more  dilute  solutions  when  injected  intravenously, 
one might  expect concentrated  solutions to be the more dangerous. 
As  a  matter  of  fact,  in  a  number  of  cases  in  which  death  was 
reported  in  man  and  animals,  following  intravenous  injections  of 
acid  salvarsan  solutions,  we  find  that  solutions  of high  concentra- 
tion  were  used.  Fraenkel  and  Grouven  6  reported  the  death  of  a 
patient  who  received  a  2.5  per  cent.  solution;  Willige ~ lost  a  case 
after using a  2 per cent.  solution; and Miessner  8 reported the death 
of several cattle that  received a  5 per cent.  solution. 
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